Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Multi-Omics DNA Methylation Analysis of MYD88 Wild-Type Waldenstrom Macroglobulinemia Reveals Potential Epigenetic Influence on Oncogenic Pathways

Blood (2024) 144 (Supplement 1): 6201.

https://doi.org/10.1182/blood-2024-205509

Published: 2024

Journal Articles

Highlighting Success: Asian Minority Representation in the Hematology-Oncology Workforce

Lewis T Go, Lucas T Go, Madugodaralalaage DSK Gunaratne, Aneel A Ashrani, Michelle A Elliott, Richard C Godby, C Christopher Hook, Leslie J Padrnos, Rajiv K Pruthi, Candido E Rivera, Rachelle L Rouse, Surbhi Shah, Marwan E Shaikh, Mustaqeem A Siddiqui, Meera Sridharan, Ewa M Wysokinska, Alexandra P Wolanskyj-Spinner, Ronald S Go, Jithma P Abeykoon

Blood (2024) 144 (Supplement 1): 7946.

https://doi.org/10.1182/blood-2024-199887

Published: 2024

Journal Articles

Subclassification of Erdheim-Chester Disease: Distinct Clinical and Molecular Findings between Classical and Non-Classical Forms

Blood (2024) 144 (Supplement 1): 3181.

https://doi.org/10.1182/blood-2024-193841

Published: 2024

Journal Articles

Assessment of Classical Hematologists and Hematology-Focused Fellowship Programs at NCI-Designated Cancer Centers: Implications for Addressing Workforce Shortages and Enhancing Mentorship Opportunities

Lewis T Go, Lucas T Go, Madugodaralalaage DSK Gunaratne, Aneel A Ashrani, Michelle A Elliott, Richard C Godby, C Christopher Hook, Leslie J Padrnos, Rajiv K Pruthi, Candido E Rivera, Rachelle L Rouse, Surbhi Shah, Marwan E Shaikh, Mustaqeem A. Siddiqui, Meera Sridharan, Ewa M Wysokinska, Alexandra P Wolanskyj-Spinner, Ronald S Go, Jithma P Abeykoon

Blood (2024) 144 (Supplement 1): 613.

https://doi.org/10.1182/blood-2024-194745

Published: 2024

Journal Articles

Cyclin D1 Overexpression in Mantle Cell Lymphoma Causes Cellular Dependence on Microhomology-Mediated End-Joining

Jithma P Abeykoon, Shuhei Asada, Guangli Zu, Yuna Hirohashi, Divya Iyer, Kalindi Parmar, Lige Jiang, Sirisha Mukkavalli, Dongni Yi, Michelle Manske, Xiaosheng Wu, Kimberly Gwin, Thomas E. Witzig, Geoffrey I Shapiro, Alan D. D'Andrea

Blood (2024) 144 (Supplement 1): 2747.

https://doi.org/10.1182/blood-2024-205197

Published: 2024

Journal Articles

High Prevalence of Concomitant Autoimmunity in Patients with Rosai-Dorfman Disease

Mitali Sen, Gordon J Ruan, Samuel B Reynolds, Haadi Ali, XI Yang, Diana Morlote, Aishwarya Ravindran, Lauren Kelly Shea, Matthew J Koster, Jithma P Abeykoon, Hind Salama, Xinxin Cao, Asra Z. Ahmed, Ronald S Go, Gaurav Goyal

Blood (2024) 144 (Supplement 1): 3910.

https://doi.org/10.1182/blood-2024-201817

Published: 2024

Journal Articles

Efficacy of Small Molecule Kinase Inhibitors in Histiocytic Neoplasms with Non-BRAFV600E Mutations: Concordance of Pre-Clinical Predictions to Clinical Responses

Alanis Enid Rodriguez-Rosario, Aldo Adrian Acosta Medina, N. Nora Bennani, Gaurav Goyal, Aishwarya Ravindran, Karen L Rech, Gordon J Ruan, Mithun V Shah, Dongni Yi, Saurabh Zanwar, Jithma P Abeykoon, Ronald S Go

Blood (2024) 144 (Supplement 1): 4564.

https://doi.org/10.1182/blood-2024-205474

Published: 2024

Journal Articles

Efficacy of Targeted Agents and Immune Checkpoint Inhibitors in Patients with Malignant Histiocytosis

Blood (2024) 144 (Supplement 1): 4563.

https://doi.org/10.1182/blood-2024-204398

Published: 2024

Journal Articles

Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation

Blood (2024) 144 (12): 1284–1289.

https://doi.org/10.1182/blood.2023023639

Published: 2024

Includes: Supplemental data

Journal Articles

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

Blood (2023) 142 (18): 1570–1575.

https://doi.org/10.1182/blood.2023021212

Published: 2023

Includes: Supplemental data

Journal Articles

Gastrointestinal Manifestation of Langerhans Cell Histiocytosis

Yuan Yao, Saurabh Zanwar, Aldo A. Acosta Medina, Gordon Ruan, Jithma P. Abeykoon, Jason R. Young, Karen Rech, Aishwarya Ravindran, Ronald Go

Blood (2022) 140 (Supplement 1): 12259–12260.

https://doi.org/10.1182/blood-2022-165511

Published: 2022

Journal Articles

Waldenstrom Macroglobulinemia and the Clinical Implications of Acquired Von Willebrand Syndrome

Karan Chohan, Saurabh Zanwar, Ronald Go, Jonas Paludo, Carrie A. Thompson, Asher Chanan-Khan, Sikander Ailawadhi, Thomas M. Habermann, Thomas E. Witzig, Morie A Gertz, Stephen M. Ansell, Shaji K Kumar, Rajiv K. Pruthi, William L. Nichols, Prashant Kapoor, Meera Sridharan, Jithma P. Abeykoon

Blood (2022) 140 (Supplement 1): 9363–9365.

https://doi.org/10.1182/blood-2022-168232

Published: 2022

Journal Articles

Hypomagnesemia and Prognosis in Newly Diagnosed Diffuse Large B Cell Lymphoma

Jennifer Jane Gile, Alexandra Smith, Matthew J. Maurer, Gordon Ruan, Jithma P. Abeykoon, M Molly McMahon, Thomas E. Witzig

Blood (2022) 140 (Supplement 1): 11919–11920.

https://doi.org/10.1182/blood-2022-156361

Published: 2022

Journal Articles

Efficacy of MEK Inhibitors in Erdheim Chester Disease

Aldo A. Acosta Medina, Saurabh Zanwar, Gordon Ruan, Jithma P. Abeykoon, Karen Rech, Aishwarya Ravindran, N. Nora Bennani, Caroline J Davidge-Pitts, Matthew Koster, Jay Ryu, Mithun V. Shah, W. Oliver Tobin, Robert Vassallo, Jason R. Young, Gaurav Goyal, Ronald Go

Blood (2022) 140 (Supplement 1): 9733–9734.

https://doi.org/10.1182/blood-2022-163674

Published: 2022

Journal Articles

High Prevalence of Epigenetic Mutations in Histiocytic and Dendritic Cell Disorders: Results from Molecular Analysis of a Large Cohort from Histiocytosis Working Group

Blood (2022) 140 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2022-162855

Published: 2022

Journal Articles

An Ex Vivo Monocyte Stimulation Test Predicts Severity of COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia (CLL)

Gordon Ruan, Xiaosheng Wu, Kimberly Gwin, Michelle K. Manske, Jithma P. Abeykoon, Taylor L. Witter, Matthew J. Schellenberg, Kari G Rabe, Sara J. Achenbach, Neil E. Kay, Sameer A. Parikh, Thomas E. Witzig

Blood (2022) 140 (Supplement 1): 8314–8315.

https://doi.org/10.1182/blood-2022-156815

Published: 2022

Journal Articles

Secreted Sars-Cov-2 Encoded ORF8 Protein Stimulates Pro-Inflammatory Cytokines and Predicts Severe Clinical Outcome

Michelle K. Manske, Xiaosheng Wu, Gordon Ruan, Taylor L. Witter, Kimberly Gwin, Kevin E. Nowakowski, Jithma P. Abeykoon, Xinyi Tang, Yue Yu, Jonas Paludo, Surendra Dasari, Stephen M. Ansell, Andrew D. Badley, Matthew J. Schellenberg, Thomas E. Witzig

Blood (2022) 140 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2022-162574

Published: 2022

Journal Articles

Mutational Profiling of Rosai-Dorfman Disease and Association with Phenotype: A Multi-Institutional Study

Gordon Ruan, Jithma P. Abeykoon, Aldo A. Acosta Medina, Saurabh Zanwar, Aishwarya Ravindran, Karen Rech, Jason R. Young, Jay Ryu, Matthew Koster, W. Oliver Tobin, Mithun V. Shah, N. Nora Bennani, Robert Vassallo, Baylie Brooks, Ginny-Tyler Meadows, Abby McCrory, Diana Morlote, Gaurav Goyal, Ronald Go

Blood (2022) 140 (Supplement 1): 3995–3996.

https://doi.org/10.1182/blood-2022-159714

Published: 2022

Journal Articles

Prevalence and Impact of Clonal Hematopoiesis in Therapy Related Myeloid Neoplasms Occurring in the Context of Low-Grade Follicular Lymphoma Treated with Radioisotope Therapy

Zhuoer Xie, Terra Lasho, Arushi Khurana, Alejandro Ferrer, Christy Finke, Abhishek A. Mangaonkar, Stephen M. Ansell, Jenna A. Fernandez, Mithun V. Shah, Aref Al-Kali, Naseema Gangat, Jithma P. Abeykoon, Thomas E. Witzig, Mrinal M.M. Patnaik

Blood (2022) 140 (Supplement 1): 11403–11405.

https://doi.org/10.1182/blood-2022-165124

Published: 2022

Journal Articles

Bortezomib and/or Daratumumab for Treatment of Refractory Autoimmune Hemolytic Anemia

John McGlothlin, Jithma P. Abeykoon, Eyad Al-Hattab, Aneel A. Ashrani, Michelle A Elliott, Ronald Go, C. Christopher Hook, Animesh Pardanani, Rajiv K. Pruthi, Meera Sridharan, Alexandra P. Wolanskyj

Blood (2022) 140 (Supplement 1): 5328–5330.

https://doi.org/10.1182/blood-2022-159270

Published: 2022

NARROW

Multi-Omics DNA Methylation Analysis of MYD88 Wild-Type Waldenstrom Macroglobulinemia Reveals Potential Epigenetic Influence on Oncogenic Pathways

Highlighting Success: Asian Minority Representation in the Hematology-Oncology Workforce

Subclassification of Erdheim-Chester Disease: Distinct Clinical and Molecular Findings between Classical and Non-Classical Forms

Assessment of Classical Hematologists and Hematology-Focused Fellowship Programs at NCI-Designated Cancer Centers: Implications for Addressing Workforce Shortages and Enhancing Mentorship Opportunities

Cyclin D1 Overexpression in Mantle Cell Lymphoma Causes Cellular Dependence on Microhomology-Mediated End-Joining

High Prevalence of Concomitant Autoimmunity in Patients with Rosai-Dorfman Disease

Efficacy of Small Molecule Kinase Inhibitors in Histiocytic Neoplasms with Non-BRAFV600E Mutations: Concordance of Pre-Clinical Predictions to Clinical Responses

Efficacy of Targeted Agents and Immune Checkpoint Inhibitors in Patients with Malignant Histiocytosis

Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

Gastrointestinal Manifestation of Langerhans Cell Histiocytosis

Waldenstrom Macroglobulinemia and the Clinical Implications of Acquired Von Willebrand Syndrome

Hypomagnesemia and Prognosis in Newly Diagnosed Diffuse Large B Cell Lymphoma

Efficacy of MEK Inhibitors in Erdheim Chester Disease

High Prevalence of Epigenetic Mutations in Histiocytic and Dendritic Cell Disorders: Results from Molecular Analysis of a Large Cohort from Histiocytosis Working Group

An Ex Vivo Monocyte Stimulation Test Predicts Severity of COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia (CLL)

Secreted Sars-Cov-2 Encoded ORF8 Protein Stimulates Pro-Inflammatory Cytokines and Predicts Severe Clinical Outcome

Mutational Profiling of Rosai-Dorfman Disease and Association with Phenotype: A Multi-Institutional Study

Prevalence and Impact of Clonal Hematopoiesis in Therapy Related Myeloid Neoplasms Occurring in the Context of Low-Grade Follicular Lymphoma Treated with Radioisotope Therapy

Bortezomib and/or Daratumumab for Treatment of Refractory Autoimmune Hemolytic Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only